FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1857-1858 December 9, 1999 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Husson, R. N. PubMed Citation

To the Editor: In the July 29 Case Record,¹ a 10-month-old infant with pulmonary tuberculosis was discharged while receiving antituberculous treatment that included ethambutol. The use of ethambutol in a patient of this age is fraught with danger.

Retrobulbar optic neuritis is the most serious adverse effect of ethambutol. Axial or central neuritis — the only form reported in patients taking ethambutol in daily doses of less than 30 mg per kilogram of body weight — involves the papillomacular bundle of fibers and results in reduced visual acuity, central scotoma, and loss of the ability to see green. Symptoms of . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.